Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia

Current Hematologic Malignancy Reports · Published 2026-07-13 · DOI 10.1007/s11899-026-00782-5

Free full text

Authors (5)

Liesl S. Eibschutz, Samuel Crow, Caroline Tatum, Daniel Reed, Michael Keng

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Eibschutz, L., Crow, S., Tatum, C., et al. (2026). Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia. Current Hematologic Malignancy Reports. https://doi.org/10.1007/s11899-026-00782-5

Related articles

• Prognostic and Predictive Models in Myelofibrosis · Current Hematologic Malignancy Reports · 2024 · Same journal
• Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms · Current Hematologic Malignancy Reports · 2026 · Same journal
• Splicing Factor Mutations in Chronic Myelomonocytic Leukemia: Biological Consequences and Therapeutic Implications · Current Hematologic Malignancy Reports · 2025 · Same journal
• From MRD To Match: the Role of Allogeneic Hematopoietic Cell Transplant in Philadelphia-Negative B-ALL · Current Hematologic Malignancy Reports · 2025 · Same journal
• How Do We Manage Chronic Lymphocytic Leukemia in India · Current Hematologic Malignancy Reports · 2024 · Same journal
• Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection · Current Hematologic Malignancy Reports · 2024 · Same journal
• Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia · Current Hematologic Malignancy Reports · 2024 · Same journal
• Maintenance Therapy Post-Stem Cell Transplantation for Patients with T-Cell Lymphomas · Current Hematologic Malignancy Reports · 2024 · Same journal
• Allogeneic Transplant for CMML · Current Hematologic Malignancy Reports · 2025 · Same journal
• Transplantation and Cellular Therapy for Older Adults—The MSK Approach · Current Hematologic Malignancy Reports · 2024 · Same journal